Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions Global CRO to demonstrate how data visualization can improve the conduct of clinical trials in a free webinar WHAT: Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, will discuss how ongoing access to real-time clinical study data and metrics is essential for efficient start-up and conduct of clinical trials in an upcoming webinar, “Using Advanced Data Visualization to Power Up Clinical Trials.” The webinar will take place on Wednesday, April 27, from 2-3 p.m. EST.

Kyruus and Hyro Form Partnership to Help Healthcare Organizations Boost Online Conversion through Digital Self-Service

Partnership will Enable Healthcare Organizations to Enhance Conversational AI Experiences with Robust Provider Search and Scheduling Capabilities

Kyruus and Upfront Partner to Enable Healthcare Organizations to Maximize Digital Patient Acquisition and Retention

Partnership Offers Consumer-Centric Search and Scheduling Options While Closing Gaps in Care through Personalized Digital Outreach to Patients

Exogene raises $2 million for its AI platform to discover cell therapies for cancer

Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.

Creative Enzymes to Exhibit at the PEGS Boston Summit on May 2-6, 2022

NorthX Biologics signs GMP manufacturing collaboration agreement with Abera Bioscience

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.

PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System

First-of-its-kind automated ultrasound platform now part of PerkinElmer portfolio aims to accelerate preclinical research

Abzena Opens a New Biologics Testing Lab to Support Partners Programs

Watson-Marlow Fluid Technology Solutions’ new name reflects strategy focused on delivering end-to-end fluid management solutions for customers

Watson-Marlow Fluid Technology Group - part of Spirax-Sarco Engineering plc, a FTSE 100 company - today announces it has changed its name to Watson-Marlow Fluid Technology Solutions (WMFTS). As the company evolves to meet the needs of the sectors in which it operates, following a successful period of global growth, the name change aligns with a strategic commitment to providing end-to-end fluid management solutions for customers.

BioIVT Appoints Jennifer Murphy as Senior Vice President of Global Commercial Operations

Jennifer has more than 16 years’ commercial leadership experience in the diagnostics and life sciences industries.

Connectivity, Sustainability and User Experience to transform packaging and drug delivery in next year: Pharmapack Europe 2022

Hataali wins US patent for the use of blockchain in advanced medicinal therapy products

Ripple Science and Curavit Clinical Research Sign Partnership Agreement to Accelerate Decentralized Clinical Trials (DCTs)

Ripple Enterprise software to be deployed as part of the digital transformation in clinical trials spearheaded by Curavit.

Rousselot Biomedical announces the world’s first GelMA produced under GMP

/ Rousselot®, Darling Ingredients’ health brand, and the global leader of collagen-based solutions announces the launch of GMP grade GelMA. X-Pure® GelMA is the first gelatin methacryloyl, or GelMA, on the market to be produced under GMP conditions.

BigOmics closes Pre-Series A with additional investment from Eppendorf

BigOmics Analytics, a Swiss biodata analytics startup, announces raising additional funding from Eppendorf, a leading life science company that develops and sells instruments, consumables and services for liquid, sample and cell handling in laboratories worldwide. The additional funding brings the total amount raised so far to CHF 2.7M. It will be used to further develop BigOmics’ platforms, to expand its team and to grow its presence in the market.

TGen Selects MemVerge to Accelerate Idiopathic Pulmonary Fibrosis Research Discovery with Big Memory Technology

Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is using MemVerge Memory Machine Big Memory virtualization software to accelerate time to discovery for Idiopathic Pulmonary Fibrosis (IPF), a disease which affects 100,000 people annually in the U.S. Using MemVerge Big Memory technology, TGen is able to dramatically speed analytical processing by nearly 36% for single-cell RNA sequencing.

Alfa Chemistry Optimizes Supply of Glycerides: Monoglycerides, Diglycerides, Triglycerides

Ever since the launch of a wide range of glycerides in the first quarter of last year, there are increasing in-coming demands for glycerides from clients across the globe. To improve user experience, Alfa Chemistry announces to upgrade and optimize this product line by further diversifying the supply of different types of glycerides, including monoglycerides, diglycerides, triglycerides.

CD Formulation Launches Tailed Solutions for Increased Bioavailability Excipients

In a recent statement, the York-based CRO company CD Formulation announces the launch of tailored solutions for increased bioavailability excipients, which aims to tackle the issue of poor bioavailability, a long-lasting challenge in drug development.

Newly Updated: Alfa Chemistry Introduces Environmental Standards to Achieve Fast and Accurate Environmental Analysis

Famed as a supplier of varieties of analytical reagents, Alfa Chemistry never let its customers down and always put customers’ concerns and needs in the first place. Hence, the company recently introduces environmental standards, which is a step to further diversify its offering of chromatography standards and also in response to the increasing needs for environmental analysis.

Canopy Launches Out of Stealth With $13 Million to Help Oncology Practices Adopt a Proactive Care Delivery Model

Canopy Launches Out of Stealth With $13 Million to Help Oncology Practices Adopt a Proactive Care Delivery Model